Mark E. Pepin

1.3k total citations
36 papers, 751 citations indexed

About

Mark E. Pepin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark E. Pepin has authored 36 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark E. Pepin's work include Cardiovascular Function and Risk Factors (8 papers), Epigenetics and DNA Methylation (7 papers) and Innovations in Medical Education (5 papers). Mark E. Pepin is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Epigenetics and DNA Methylation (7 papers) and Innovations in Medical Education (5 papers). Mark E. Pepin collaborates with scholars based in United States, Germany and Italy. Mark E. Pepin's co-authors include Adam R. Wende, Manoja K. Brahma, Chae‐Myeong Ha, Rajat M. Gupta, Stavros G. Drakos, Bruce C. Bunker, Dale L. Huber, Mark E. Roberts, Amy Patton and Matthew G. MacKenzie and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark E. Pepin

34 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Pepin United States 16 347 179 153 136 125 36 751
Takahiro Araki Japan 17 177 0.5× 112 0.6× 124 0.8× 169 1.2× 176 1.4× 37 848
Yanshuo Han China 17 344 1.0× 129 0.7× 44 0.3× 108 0.8× 152 1.2× 64 911
Buket Kosova Türkiye 21 445 1.3× 90 0.5× 50 0.3× 57 0.4× 57 0.5× 72 1.0k
Wenhui Zhang China 14 145 0.4× 100 0.6× 67 0.4× 56 0.4× 73 0.6× 63 655
Kyeong‐Min Lee South Korea 18 260 0.7× 60 0.3× 50 0.3× 107 0.8× 282 2.3× 36 838
Shouyan Zhang China 15 245 0.7× 139 0.8× 207 1.4× 26 0.2× 31 0.2× 50 683
Matthias Laudes Germany 13 277 0.8× 50 0.3× 145 0.9× 25 0.2× 94 0.8× 28 681
Gregory B. Lim United States 12 279 0.8× 318 1.8× 118 0.8× 73 0.5× 164 1.3× 278 886
Qianli Yu United States 12 241 0.7× 316 1.8× 50 0.3× 39 0.3× 58 0.5× 33 720
Yuxia Chen China 14 255 0.7× 92 0.5× 37 0.2× 48 0.4× 72 0.6× 65 716

Countries citing papers authored by Mark E. Pepin

Since Specialization
Citations

This map shows the geographic impact of Mark E. Pepin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Pepin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Pepin more than expected).

Fields of papers citing papers by Mark E. Pepin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Pepin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Pepin. The network helps show where Mark E. Pepin may publish in the future.

Co-authorship network of co-authors of Mark E. Pepin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Pepin. A scholar is included among the top collaborators of Mark E. Pepin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Pepin. Mark E. Pepin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Jyoti, et al.. (2026). Decoding Vascular Cell Diversity: Single-Cell Approaches to Mechanisms of Vascular Disease. Circulation Research. 138(1). e326001–e326001. 1 indexed citations
2.
Pepin, Mark E., Sumra Nazir, Christoph Maack, et al.. (2025). Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF. Circulation Research. 136(12). 1564–1578. 5 indexed citations
3.
Schiano, Concetta, Teresa Infante, Giuditta Benincasa, et al.. (2025). DNA hypermethylation of MED1 and MED23 as early diagnostic biomarkers for unsolved issues in atrial fibrillation. International Journal of Cardiology. 429. 133179–133179. 2 indexed citations
4.
Pepin, Mark E., Shamsudheen Karuthedath Vellarikkal, Deepak Atri, et al.. (2025). Integrative analysis of single-cell transcriptomics and genetic associations identify cell states associated with vascular disease. Atherosclerosis. 403. 119108–119108. 1 indexed citations
5.
Benincasa, Giuditta, Mark E. Pepin, Francesco Cacciatore, et al.. (2023). DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction. European Heart Journal. 44(Supplement_2). 1 indexed citations
6.
Pepin, Mark E. & Rajat M. Gupta. (2023). The Role of Endothelial Cells in Atherosclerosis. American Journal Of Pathology. 194(4). 499–509. 31 indexed citations
7.
Oeing, Christian U., Mark E. Pepin, Yassen Assenov, et al.. (2023). Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure. Basic Research in Cardiology. 118(1). 9–9. 9 indexed citations
8.
Pepin, Mark E., Markus Grosch, Sandra Clauder‐Münster, et al.. (2022). Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 323(6). H1296–H1310. 7 indexed citations
9.
Pepin, Mark E., et al.. (2022). Fostering a diverse regional community of physician-scientist trainees. Journal of the National Medical Association. 114(3). 251–257. 3 indexed citations
10.
Pepin, Mark E., et al.. (2022). A novel curricular framework to develop grant writing skills among MD–PhD students. Journal of Clinical and Translational Science. 6(1). e54–e54. 3 indexed citations
11.
Pepin, Mark E., Chae‐Myeong Ha, Steven M. Pogwizd, et al.. (2021). Racial and socioeconomic disparity associates with differences in cardiac DNA methylation among men with end-stage heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 320(5). H2066–H2079. 15 indexed citations
12.
Pepin, Mark E., et al.. (2021). A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke. SHILAP Revista de lepidopterología. 9(10). e04850–e04850. 1 indexed citations
13.
Pepin, Mark E., Concetta Schiano, Marco Miceli, et al.. (2021). The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia. Experimental Cell Research. 400(2). 112485–112485. 31 indexed citations
14.
Quiles, Justin M., Mark E. Pepin, Sandeep B. Shelar, et al.. (2021). Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress. Scientific Reports. 11(1). 11977–11977. 18 indexed citations
15.
Brahma, Manoja K., Chae‐Myeong Ha, Mark E. Pepin, et al.. (2020). Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization. Journal of the American Heart Association. 9(15). e013039–e013039. 52 indexed citations
16.
Pepin, Mark E., Stavros G. Drakos, Chae‐Myeong Ha, et al.. (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 317(4). H674–H684. 59 indexed citations
17.
Pepin, Mark E., et al.. (2019). Prolactin Receptor Signaling Regulates a Pregnancy-Specific Transcriptional Program in Mouse Islets. Endocrinology. 160(5). 1150–1163. 19 indexed citations
18.
Pepin, Mark E., William M. Webb, Sushma Boppana, et al.. (2019). Gamification: an Innovative Approach to Reinforce Clinical Knowledge for MD-PhD Students During Their PhD Research Years. Medical Science Educator. 29(3). 739–747. 11 indexed citations
19.
Pepin, Mark E., Chae‐Myeong Ha, David K. Crossman, et al.. (2018). Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. Laboratory Investigation. 99(3). 371–386. 71 indexed citations
20.
MacKenzie, Matthew G., D. Lee Hamilton, Mark E. Pepin, Amy Patton, & Keith Baar. (2013). Inhibition of Myostatin Signaling through Notch Activation following Acute Resistance Exercise. PLoS ONE. 8(7). e68743–e68743. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Araki Breakdown of academic impact, for papers by Yanshuo Han Breakdown of academic impact, for papers by Buket Kosova Breakdown of academic impact, for papers by Wenhui Zhang Breakdown of academic impact, for papers by Kyeong‐Min Lee Breakdown of academic impact, for papers by Shouyan Zhang Breakdown of academic impact, for papers by Matthias Laudes Breakdown of academic impact, for papers by Gregory B. Lim Breakdown of academic impact, for papers by Qianli Yu Breakdown of academic impact, for papers by Yuxia Chen
Rankless by CCL
2026